PepAxiom

Cognitive / neuro

P21

Preclinical (animal)

P021 · CNTF-derived neurogenic peptide

Experimental neurogenic peptide derived from CNTF.

Half-life
Not established in humans
Route
Research (oral/injectable)
Evidence
Preclinical / animal only; no human trials.

What it is

A small peptidergic compound from a fragment of ciliary neurotrophic factor, engineered for stability and brain penetration.

How it works

Enhances BDNF signaling and neurogenesis and inhibits abnormal tau hyperphosphorylation in models.

Studied for

Neurogenesis, Alzheimer's/tauopathy models, cognition.

Regulatory status

Not approved; research chemical.

Safety

No human safety data; experimental only.

Reconstitution calculator →

Educational information only — not medical advice, and not a recommendation to use any compound. Many peptides here are not approved for human use; legal status and evidence quality vary and are noted above. This page contains no dosing information. Consult a qualified clinician before making any health decision.